You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced or metastatic differentiated thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Locally Advanced or Metastatic Radioiodine-Refractory

Recruiting
  • Thyroid Neoplasms
  • Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +2 more
Aug 9, 2023

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)

Recruiting
  • DTC - Differentiated Thyroid Cancer
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

Thyroid Cancer Trial in Worldwide (Irofulven + capecitabine)

Completed
  • Thyroid Cancer
  • Irofulven + capecitabine
  • Aurora, Colorado
  • +9 more
Jun 11, 2021

Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Recruiting
  • Differentiated Thyroid Cancer
  • Caba, Buenos Aires, Argentina
  • +41 more
Nov 25, 2022

Differentiated Thyroid Cancer Trial in Nanjing, Peking (Apatinib Oral Tablet, Placebo Oral Tablet)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Apatinib Oral Tablet
  • Placebo Oral Tablet
  • Nanjing, Jiangsu, China
  • +1 more
Aug 9, 2021

Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8

Suspended
  • Metastatic Thyroid Gland Carcinoma
  • +2 more
  • Saint Petersburg, Russian Federation
    Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021

Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

Recruiting
  • Thyroid Cancer
  • Traditional neck dissection approach
  • Anterior neck dissection approach
  • Medellin, Antioquia, Colombia
    Hospital Alma Mater de Antioquia
Nov 20, 2023

Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

Active, not recruiting
  • Thyroid Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 8, 2022

Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

Not yet recruiting
  • Non-Medullary Thyroid Carcinoma
  • Digoxin tablet
  • (no location specified)
Aug 20, 2022

Differentiated Thyroid Cancer, Advanced Cancer Trial in Boston (LENVATINIB)

Recruiting
  • Differentiated Thyroid Cancer
  • Advanced Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2022

Thyroid Cancer Trial in Peking (Apatinib)

Completed
  • Thyroid Cancer
  • Peking, China
    Peking Union Medical College Hospital
Jan 18, 2022

Differentiated Thyroid Cancer Trial in Worldwide (Vandetanib (SAR390530), Placebo)

Active, not recruiting
Has Results
  • Differentiated Thyroid Cancer
  • Vandetanib (SAR390530)
  • Placebo
  • Little Rock, Arkansas
  • +60 more
Oct 20, 2021

HRQOL in Locally Advanced Thyroid Carcinoma

Recruiting
  • Thyroid Cancer
  • +2 more
  • Tyrosine kinase inhibitor drugs.
  • Fuzhou, Fujian, China
    Road Fuma No.420
Apr 11, 2023

Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Oviedo, Asturias, Spain
  • +9 more
Dec 14, 2022

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Thyroid Tumors Trial in India (Lenvatinib)

Active, not recruiting
  • Thyroid Neoplasms
  • New Delhi, Delhi, India
  • +10 more
Jul 15, 2022

Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland

Not yet recruiting
  • Locally Advanced Thyroid Gland Anaplastic Carcinoma
  • +2 more
  • Chicago, Illinois
  • +1 more
Jul 7, 2022

Thyroglobulin Point of Care Assay for Rapid Detection of

Recruiting
  • Differentiated Thyroid Cancer
  • Lymph Node Metastases
  • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
  • Ashkelon, Israel
  • +2 more
Oct 25, 2022

Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)

Recruiting
  • Thyroid Cancer
  • Anlotinib hydrochloride
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

Thyroid Cancer Trial in Palo Alto (Pembrolizumab (Keytruda))

Recruiting
  • Thyroid Cancer
  • Pembrolizumab (Keytruda)
  • Palo Alto, California
    Stanford University
Feb 16, 2022

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021